Peptides for Recovery and Injury Repair

Introduction

Recovery peptides have gained significant attention for their potential to accelerate healing and improve recovery. This section covers the major recovery peptides and their applications.

Key Recovery Peptides

BPC-157 (Body Protection Compound)

Aspect	Details	Notes
Origin	Gastric juice derivative	Stable fragment
Primary actions	Angiogenesis, tendon healing	Well-documented in animals
Administration	Injection (SC) or oral	Route affects target
Typical dose	250-500 mcg/day	Split into 1-2 doses

TB-500 (Thymosin Beta-4 Fragment)

Aspect	Details	Notes
Origin	Thymosin beta-4 active fragment	Naturally occurring
Primary actions	Cell migration, differentiation	Tissue regeneration
Administration	Subcutaneous injection	Systemic effects
Typical dose	2-2.5 mg, 2x/week	Loading then maintenance

MGF (Mechano Growth Factor)

Aspect	Details	Notes
Origin	IGF-1 splice variant	Exercise-induced
Primary actions	Satellite cell activation	Muscle-specific
Administration	Local injection	Near target tissue
Typical dose	100-200 mcg	Post-workout

Injury-Specific Applications

Tendon Injuries

Peptide	Protocol	Expected Timeline
BPC-157	250-500 mcg/day, near site	4-8 weeks
TB-500	2.5 mg 2x/week	4-6 weeks
Combination	Both peptides	Enhanced effect

Muscle Tears

Peptide	Protocol	Expected Timeline
TB-500	2.5 mg 2x/week	4-6 weeks
BPC-157	250 mcg 2x/day	Support role
MGF	100-200 mcg locally	Post-injury

Ligament Injuries

Peptide	Protocol	Notes
BPC-157 + TB-500	Full doses of both	Complementary mechanisms
Duration	6-12 weeks	Slow-healing tissue
Adjuncts	Physical therapy essential	Peptides support healing

General Recovery Enhancement

Post-Workout Recovery

Approach	Peptides	Timing
GH optimization	GHRP + GHRH combo	Post-workout, before bed
Tissue support	Low-dose BPC-157	Daily
Sleep enhancement	GH peptides at night	30 min before bed

Overtraining Recovery

Strategy	Implementation	Duration
Reduced training	Deload period	1-2 weeks
Recovery peptides	Standard protocols	During recovery
Monitoring	Subjective + objective	Track improvement

Evidence Assessment

Research Quality by Peptide

Peptide	Animal Data	Human Data	Confidence
BPC-157	Strong	Limited/anecdotal	Moderate
TB-500	Moderate	Limited/anecdotal	Moderate
MGF	Limited	Very limited	Low

Conclusion

Recovery peptides offer promising potential for accelerated healing, but evidence is primarily from animal studies. Conservative protocols with realistic expectations are advisable.